# Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients

> **NCT02855112** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 10 (estimated)

## Conditions studied

- Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]

## Interventions

- **BIOLOGICAL:** Adipose derived mesenchymal stem cell

## Key facts

- **NCT ID:** NCT02855112
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2016-12
- **Final completion:** 2017-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2016-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02855112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02855112, "Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02855112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*